EGFR and non-small cell lung carcinoma: Therefore, the purpose of this study was to explore the predictive effect of brain MRI radiomics on the intracranial efficacy of osimertinib treatment in advanced NSCLC patients with brain metastases after the failure of the first-line EGFR-TKI.